Revolut partners with OpenAI to bundle ChatGPT Go into its subscriptions
Fintech and ecommerce
Launch your PR campaign on TNW Reach founders, executives, and tech decision-makers across the US and Europe.
Learn More
Russia charges Telegram’s Durov with aiding terrorism and adds him to a wanted list
Government and policy
Launch your PR campaign on TNW
Reach founders, executives, and tech decision-makers across the US and Europe.
Learn More
Latest news
INVESTORS AND FUNDING
AI agents are about to run the enterprise. Onyx raised $113M to keep a human in the loop.
Onyx Security has raised a $113m Series B led by Bessemer, valuing the Israeli startup at about $640m just four months after it left stealth. Its “secure AI control plane” sits between a company’s AI agents and the systems they touch, inspecting every action and blocking the bad ones. The bet: agents are about to take most enterprise actions, and someone has to keep them accountable.
INVESTORS AND FUNDING
AI agents are about to run the enterprise. Onyx raised $113M to keep a human in the loop.
Onyx Security has raised a $113m Series B led by Bessemer, valuing the Israeli startup at about $640m just four months after it left stealth. Its “secure AI control plane” sits between a company’s AI agents and the systems they touch, inspecting every action and blocking the bad ones. The bet: agents are about to take most enterprise actions, and someone has to keep them accountable.
HEALTH TECH
Everyone’s building a ‘GPT for cells.’ Relation’s bet is manufacturing the data to train it.
Relation Therapeutics has unveiled MORGAN, an AI “foundation model of the cell” meant to predict how human cells respond to drugs and genetic changes. On the same day, it expanded a collaboration with GSK worth up to $110m, aimed at manufacturing the large-scale cellular data needed to train it. The bet: in AI drug discovery, the data is the moat.
LEGAL
The FTC is suing Hims & Hers for sharing patients’ health data with Meta and Snap
Regulators say the telehealth firm leaked sensitive health information to advertisers, charged people without consent, and made cancelling deliberately hard.
Work with us
Get in touch
